Maria Cecilia Hospital, GVM Care and Research, Cotignola, Ravenna, Italy.
J Endocrinol Invest. 2011 Jul;34(7 Suppl):13-7.
Extracellular calcium concentration changes are recognized by Ca++ sensing receptor (CaR), a member of the G-protein-coupled receptor family. Recently, progress has been made in the understanding of CaR functional role in bone cells, notwithstanding a lack of detailed knowledge about the identity of the cation receptors. It is generally agreed that a high extracellular calcium induces osteoblast proliferation and osteoclastogenesis inhibition. Potential implications that may be considered include a role for CaR in osteogenesis, in serum calcium homeostasis regulation, and as a factor coupling bone formation to resorption in bone remodeling. The localization of CaR in bone cells provides further knowledge of the mechanisms operating in the bone remodeling model; in fact, increased calcium gradient in the site of bone resorption favors osteoblast precursors chemotaxis and inhibits osteoclasts through the increase of [Ca++]e. In vitro data indicate that CaR is a physiological regulator of bone cells, regulating the recruitment, differentiation and survival of osteoblasts and osteoclasts. This leads to the concept that the CaR present in bone cells may be targeted by agonists or antagonists to control bone cell metabolism and bone remodeling.
细胞外钙离子浓度的变化被钙敏感受体(CaR)识别,CaR 是 G 蛋白偶联受体家族的成员。尽管关于阳离子受体的身份还缺乏详细的了解,但近年来人们对 CaR 在骨细胞中的功能作用有了更多的认识。一般认为,高细胞外钙离子会诱导成骨细胞增殖和破骨细胞生成抑制。可能需要考虑的潜在影响包括 CaR 在成骨、血清钙稳态调节以及作为将骨形成与骨吸收偶联的因子在骨重塑中的作用。CaR 在骨细胞中的定位为骨重塑模型中起作用的机制提供了更多的知识;事实上,在骨吸收部位钙梯度的增加有利于成骨细胞前体细胞的趋化作用,并通过增加 [Ca++]e 抑制破骨细胞。体外数据表明,CaR 是骨细胞的生理调节剂,调节成骨细胞和破骨细胞的募集、分化和存活。这就产生了一个概念,即在骨细胞中存在的 CaR 可能被激动剂或拮抗剂靶向,以控制骨细胞代谢和骨重塑。